Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
134 | Bioengineered | journal | 55 | 68 | 0 | 3076 | 0 | 0 | 0.00 | 45.24 | 33.83 | ||
133 | Cell Death and Disease | journal | 164 | 108 | 0 | 4078 | 0 | 0 | 0.00 | 37.76 | 39.67 | ||
132 | Clinical and Experimental Neuroimmunology | journal | 21 | 15 | 0 | 1239 | 0 | 0 | 0.00 | 82.60 | 20.83 | ||
131 | F1000 Biology Reports | journal | 32 | 88 | 0 | 2780 | 0 | 0 | 0.00 | 31.59 | 27.11 | ||
130 | Mycology | journal | 37 | 31 | 0 | 1085 | 0 | 0 | 0.00 | 35.00 | 36.11 | ||
129 | Immunology. Supplement | journal | 0.121 Q4 | 0 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
128 | Current Issues in Intestinal Microbiology | journal | 1.458 Q1 | 39 | 0 | 5 | 0 | 40 | 5 | 0.00 | 0.00 | 0.00 | |
127 | Journal of Viral Entry | journal | 2.423 Q1 | 2 | 21 | 5 | 245 | 11 | 4 | 2.20 | 11.67 | 25.00 | |
126 | Advances in Antiviral Drug Design | book series | 0.320 Q3 | 12 | 0 | 7 | 0 | 6 | 6 | 0.00 | 0.00 | 0.00 | |
125 | Gut Pathogens | journal | 1.009 Q2 | 56 | 21 | 7 | 890 | 25 | 6 | 3.57 | 42.38 | 31.17 | |
124 | Kinetoplastid Biology and Disease | journal | 0.996 Q2 | 23 | 0 | 7 | 0 | 19 | 7 | 0.00 | 0.00 | 0.00 | |
123 | International Congress and Symposium Series - Royal Society of Medicine | book series | 0.103 Q4 | 9 | 0 | 9 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
122 | Journal of Invasive Fungal Infections | journal | 0.102 Q4 | 4 | 14 | 13 | 940 | 0 | 13 | 0.00 | 67.14 | 23.53 | |
121 | Clinical and Experimental Allergy Reviews | journal | 0.226 Q4 | 17 | 8 | 21 | 165 | 13 | 19 | 0.92 | 20.63 | 9.09 | |
120 | Journal of Immune Based Therapies and Vaccines | journal | 0.560 Q3 | 21 | 9 | 24 | 277 | 42 | 24 | 2.08 | 30.78 | 39.29 | |
119 | Clinical and Molecular Allergy | journal | 0.666 Q3 | 42 | 16 | 28 | 626 | 74 | 26 | 2.39 | 39.13 | 43.21 | |
118 | Saline Systems | journal | 1.349 Q2 | 30 | 12 | 33 | 617 | 85 | 33 | 2.70 | 51.42 | 40.43 | |
117 | British Mycological Society Symposia Series | book series | 0.180 Q4 | 17 | 0 | 35 | 0 | 26 | 34 | 0.74 | 0.00 | 0.00 | |
116 | Journal of Nanobiotechnology | journal | 1.770 Q1 | 109 | 34 | 35 | 1349 | 250 | 33 | 5.25 | 39.68 | 26.92 | |
115 | Immunity and Ageing | journal | 0.776 Q3 | 61 | 23 | 36 | 974 | 135 | 36 | 3.37 | 42.35 | 41.57 | |
114 | Genetic Vaccines and Therapy | journal | 0.718 Q3 | 30 | 8 | 40 | 368 | 98 | 40 | 2.36 | 46.00 | 40.68 | |
113 | Environmental Microbiome | journal | 48 | 71 | 43 | 2434 | 95 | 41 | 2.21 | 34.28 | 42.47 | ||
112 | Biotechnology for Biofuels | journal | 1.823 Q1 | 129 | 34 | 44 | 1408 | 265 | 43 | 6.02 | 41.41 | 33.61 | |
111 | Critical Reviews in Microbiology | journal | 1.796 Q1 | 111 | 21 | 46 | 3630 | 286 | 45 | 5.87 | 172.86 | 39.34 | |
110 | Allergy, Asthma and Clinical Immunology | journal | 0.186 Q4 | 49 | 19 | 51 | 745 | 17 | 49 | 0.48 | 39.21 | 53.97 | |
109 | Critical Reviews in Biotechnology | journal | 1.523 Q1 | 123 | 20 | 51 | 2775 | 303 | 49 | 5.41 | 138.75 | 26.92 | |
108 | Future HIV Therapy | journal | 0.236 Q4 | 8 | 0 | 57 | 0 | 35 | 46 | 0.61 | 0.00 | 0.00 | |
107 | HIV Therapy | journal | 0.260 Q4 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | 41.84 | |
106 | Journal of HIV Therapy | journal | 0.224 Q4 | 18 | 5 | 61 | 186 | 33 | 51 | 0.59 | 37.20 | 16.67 | |
105 | Antiviral Chemistry and Chemotherapy | journal | 0.590 Q3 | 59 | 23 | 66 | 980 | 150 | 64 | 2.32 | 42.61 | 20.83 | |
104 | Mathematical Medicine and Biology | journal | 0.544 Q3 | 49 | 7 | 69 | 257 | 94 | 69 | 1.29 | 36.71 | 20.00 | |
103 | International Reviews of Immunology | journal | 1.252 Q2 | 77 | 30 | 73 | 3388 | 220 | 64 | 3.24 | 112.93 | 33.33 | |
102 | Food and Agricultural Immunology | journal | 0.281 Q4 | 43 | 31 | 81 | 930 | 59 | 81 | 0.73 | 30.00 | 36.51 | |
101 | AIDS Research and Therapy | journal | 0.866 Q2 | 49 | 47 | 84 | 1626 | 198 | 84 | 2.04 | 34.60 | 39.35 | |
100 | Reviews in Medical Virology | journal | 2.956 Q1 | 106 | 32 | 90 | 3190 | 591 | 72 | 5.18 | 99.69 | 32.84 | |
99 | Parasites and Vectors | journal | 0.980 Q2 | 111 | 114 | 103 | 5478 | 270 | 101 | 2.62 | 48.05 | 28.80 | |
98 | Innate Immunity | journal | 0.931 Q2 | 78 | 44 | 104 | 2182 | 294 | 101 | 2.85 | 49.59 | 40.78 | |
97 | Comparative Immunology, Microbiology and Infectious Diseases | journal | 1.127 Q2 | 65 | 62 | 114 | 2006 | 387 | 108 | 3.79 | 32.35 | 36.51 | |
96 | Immunotherapy | journal | 0.348 Q3 | 65 | 93 | 115 | 5963 | 48 | 93 | 0.42 | 64.12 | 30.61 | |
95 | African Journal of AIDS Research | journal | 0.281 Q3 | 34 | 22 | 125 | 818 | 82 | 122 | 0.67 | 37.18 | 67.21 | |
94 | Journal of Neuroinflammation | journal | 2.423 Q1 | 154 | 98 | 125 | 5595 | 785 | 123 | 6.48 | 57.09 | 38.91 | |
93 | British Journal of Biomedical Science | journal | 0.274 Q3 | 48 | 42 | 126 | 1022 | 100 | 123 | 0.65 | 24.33 | 33.61 | |
92 | DMM Disease Models and Mechanisms | journal | 2.551 Q1 | 107 | 99 | 133 | 4745 | 378 | 77 | 2.84 | 47.93 | 39.35 | |
91 | Immunological Medicine | journal | 22 | 49 | 137 | 1326 | 48 | 135 | 0.39 | 27.06 | 19.59 | ||
90 | Microbial Biotechnology | journal | 0.877 Q2 | 104 | 64 | 137 | 3968 | 283 | 124 | 2.07 | 62.00 | 34.44 | |
89 | Microbiology Today | journal | 0.110 Q4 | 7 | 67 | 139 | 136 | 7 | 41 | 0.05 | 2.03 | 36.36 | |
88 | Biology Direct | journal | 2.453 Q1 | 81 | 68 | 142 | 3865 | 538 | 139 | 3.78 | 56.84 | 25.41 | |
87 | Microbial Cell Factories | journal | 1.627 Q1 | 127 | 102 | 142 | 4632 | 678 | 137 | 4.77 | 45.41 | 38.27 | |
86 | FEMS Microbiology Reviews | journal | 5.897 Q1 | 250 | 49 | 144 | 8779 | 1694 | 138 | 12.58 | 179.16 | 31.76 | |
85 | Cytokine and Growth Factor Reviews | journal | 3.085 Q1 | 182 | 54 | 147 | 5091 | 1113 | 136 | 8.53 | 94.28 | 25.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®